Corvus Pharmaceuticals Inc — Stato Patrimoniale (NASDAQ:CRVS)

Financials

Totale attivo 85.53 M109.45 M68.24 M45.55 M68.91 M71.12 M Totale passività 13.38 M12.29 M12.13 M6.87 M36.34 M9.91 M Patrimonio netto totale 72.15 M97.16 M56.12 M38.68 M32.57 M61.2 M Totale passività e patrimonio netto 85.53 M109.45 M68.24 M45.55 M68.91 M71.12 M Debito totale —————— Indebitamento netto ——————

Notizie

Corvus Pharmaceuticals Stock: Strong Clinical Narrative, Already Priced For Success (CRVS)

Cantor Fitzgerald conferma il rating sul titolo Corvus Pharmaceuticals

Cantor Fitzgerald reiterates Corvus Pharmaceuticals stock rating

Oppenheimer raises Corvus Pharmaceuticals stock price target to $33

Corvus Pharmaceuticals, Inc. (CRVS) Q4 2025 Earnings Call Transcript

Corvus Pharmaceuticals in rialzo sui dati dello studio sulla dermatite atopica

Corvus Pharmaceuticals rises on atopic dermatitis trial data

Corvus Pharmaceuticals pubblica i risultati dopo dati positivi

Corvus Pharmaceuticals earnings on deck after positive trial data

Risultati Corvus in arrivo: il fermento sulla pipeline giustifica il rally?

Corvus earnings up next: Can pipeline buzz justify stock surge?

Corvus Pharmaceuticals, Inc. (CRVS) Discusses Phase 1 Clinical Trial Results of Soquelitinib in Atopic Dermatitis with Focus on Cohort 4 - Slideshow (NASDAQ:CRVS) 2026-01-27